{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:20:48Z","timestamp":1787757648473,"version":"build-2784847793"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Rosacea is a chronic inflammatory skin disease whose etiopathogenesis is still unknown. Previous studies have shown a relationship between certain inflammatory disorders and serum endocan levels. Endocan (previously known as endothelial cell-specific molecule 1) might play a role in the pathogenesis of various inflammatory diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and Objectives:<\/jats:title>\n                    <jats:p>Our study aimed to evaluate serum endocan levels in patients with rosacea to investigate the association of endocan with the demographic data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      The study recruited individuals aged \u226518 years who voluntarily agreed to participate in the study. The participants included 37 women (mean age: 48.29 \u00b1 12.08 years) and 13 men (mean age: 52.23 \u00b1 13.34 years) diagnosed with rosacea, and 37 women (mean age: 49.18 \u00b1 16.6 years) and 13 men (mean age: 53.69 \u00b1 11.30 years) selected as controls. Both groups were matched according to age and sex. The rosacea diagnosis was based on clinical examination findings, and serum endocan levels were measured using the method of enzyme-linked immunosorbent assay (ELISA). The statistical significance of the data was determined by the Mann\u2013Whitney\n                      <jats:italic toggle=\"yes\">U<\/jats:italic>\n                      test, and a value of\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05 was considered statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Serum endocan levels differed significantly between the patients with rosacea and the control group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Circulating endocan might be a new marker related to disease progression in patients with rosacea. Further investigation is needed to determine whether endocan levels could become a new therapeutic target in rosacea, a disease that still cannot be fully cured.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_401_21","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T04:03:30Z","timestamp":1638849810000},"page":"520-524","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Elevated Serum Endocan Levels in Patients with Rosacea"],"prefix":"10.4103","volume":"66","author":[{"given":"Sevilay","family":"K\u0131l\u0131c","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selda I","family":"Mermutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal","family":"\u015eehito\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"Ekinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20240829","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1468-3083.2010.03751.x","article-title":"Rosacea - global diversity and optimized outcome: Proposed international consensus from the Rosacea International Expert Group","volume":"25","author":"Elewski","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R2-12-20240829","doi-asserted-by":"crossref","first-page":"20458","DOI":"10.1074\/jbc.271.34.20458","article-title":"ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines","volume":"271","author":"Lassalle","year":"1996","journal-title":"J Biol Chem"},{"key":"R3-12-20240829","doi-asserted-by":"crossref","first-page":"48341","DOI":"10.1074\/jbc.M108395200","article-title":"Endocan is a novel chondroitin sulfate\/dermatan sulfate proteoglycan that promotes hepatocyte growth factor\/scatter factor mitogenic activity","volume":"276","author":"B\u00e9chard","year":"2001","journal-title":"J Biol Chem"},{"key":"R4-12-20240829","first-page":"25","article-title":"Endocan or endothelial cell specific molecule-1 (ESM-1): A potential novel endothelial cell marker and a new target for cancer therapy","volume":"1765","author":"Sarrazin","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"R5-12-20240829","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/bjd.12525","article-title":"Elevated serum levels of endocan in patients with psoriasis vulgaris: Correlations with cardiovascular risk and activity of disease","volume":"169","author":"Balta","year":"2013","journal-title":"Br J Dermatol"},{"key":"R6-12-20240829","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaad.2013.09.013","article-title":"Serum endocan levels as a marker of disease activity in patients with Beh\u00e7et disease","volume":"70","author":"Balta","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R7-12-20240829","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/01.CCM.0000198525.82124.74","article-title":"Endocan, a new endothelial marker in human sepsis","volume":"34","author":"Scherpereel","year":"2006","journal-title":"Crit Care Med"},{"key":"R8-12-20240829","doi-asserted-by":"crossref","first-page":"738.e1","DOI":"10.1016\/j.urology.2012.03.019","article-title":"Detection on dynamic changes of endothelial cell specific molecule-1 in acute rejection after renal transplantation","volume":"80","author":"Li","year":"2012","journal-title":"Urology"},{"key":"R9-12-20240829","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the classification and staging of rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R10-12-20240829","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/bjd.16815","article-title":"Applying the phenotype approach for rosacea to practice and research","volume":"179","author":"Tan","year":"2018","journal-title":"Br J Dermatol"},{"key":"R11-12-20240829","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jaad.2019.03.055","article-title":"Vascular endothelial growth factor gene polymorphisms in patients with rosacea: A case-control study","volume":"81","author":"Hayran","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R12-12-20240829","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2009.04.007","article-title":"The molecular pathology of rosacea","volume":"55","author":"Yamasaki","year":"2009","journal-title":"J Dermatol Sci"},{"key":"R14-12-20240829","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1365-2133.1998.02064.x","article-title":"Tumour necrosis factor-\u03b1 is involved in the contrasting effects of ultraviolet B and ultraviolet A1 radiation on the release by normal human keratinocytes of vascular permeability factor","volume":"138","author":"Longuet-Perret","year":"1998","journal-title":"Br J Dermatol"},{"key":"R15-12-20240829","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1177\/0003319714568791","article-title":"Endocan and endothelial dysfunction","volume":"66","author":"Aparci","year":"2015","journal-title":"Angiology"},{"key":"R16-12-20240829","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/ijd.14290","article-title":"Subclinical atherosclerosis in psoriatic disease: Relation to endocan, TNF-\u03b1, age of onset, and body fat","volume":"58","author":"Elkamshoushi","year":"2019","journal-title":"Int J Dermatol"},{"key":"R17-12-20240829","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrendo.2014.114","article-title":"VEGF-targeted cancer therapeutics-paradoxical effects in endocrine organs","volume":"10","author":"Cao","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"R18-12-20240829","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.167.6.3099","article-title":"Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a\/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1","volume":"167","author":"B\u00e9chard","year":"2001","journal-title":"J Immunol"},{"key":"R19-12-20240829","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000025758","article-title":"Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies","volume":"37","author":"Bechard","year":"2000","journal-title":"J Vasc Res"},{"key":"R20-12-20240829","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/1346-8138.12465","article-title":"Comorbidities and health-related quality of life in Spanish patients with moderate to severe psoriasis: A cross-sectional study (Arizona study)","volume":"41","author":"Sanchez-Carazo","year":"2014","journal-title":"J Dermatol"},{"key":"R21-12-20240829","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/1346-8138.13974","article-title":"Increased endocan expression in lesional skin and decreased endocan expression in sera in atopic dermatitis","volume":"44","author":"Suzuki","year":"2017","journal-title":"J Dermatol"},{"key":"R22-12-20240829","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mvr.2014.04.004","article-title":"Endocan is useful biomarker of survival and severity in sepsis","volume":"93","author":"Mihajlovic","year":"2014","journal-title":"Microvasc Res"},{"key":"R23-12-20240829","doi-asserted-by":"crossref","first-page":"E63","DOI":"10.5888\/pcd17.200247","article-title":"Men and COVID-19: A biopsychosocial approach to understanding sex differences in mortality and recommendations for practice and policy interventions","volume":"17","author":"Griffith","year":"2020","journal-title":"Prev Chronic Dis"},{"key":"R24-12-20240829","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jaccas.2020.04.027","article-title":"Sex differences in mortality from COVID-19 pandemic: Are men vulnerable and women protected?","volume":"2","author":"Sharma","year":"2020","journal-title":"JACC Case Rep"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_401_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:47:38Z","timestamp":1787755658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_401_21"}},"subtitle":["A New Therapeutic Target?"],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_401_21","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}